News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Institut Pasteur and CELLECTIS SA Announce the Grant of a Key European Patent Covering the Use of Homologous Recombination in Eukaryotes


6/4/2007 5:23:41 PM

Paris and Romainville, France, June the 4th, 2007 - In a joint statement with its licensee (Cellectis S.A.), the Institut Pasteur today announced that it has been granted a broad European patent (number EP 0 682 112 B1) related to the use of homologous recombination processes in eukaryotes. The patent covers a "Method for Activating Expression, or Improving the Level of Expression of a Gene". As of today, Cellectis counts 65 patents and patents applications.

Read at press release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES